LGX

Ultra Low Insertion Loss Athermal AWG Multiplexers

Retrieved on: 
Monday, March 18, 2024

LOS ANGELES and SEOUL, South Korea, March 18, 2024 /PRNewswire/ -- POINTek, Inc., a global leader and provider of high performance high-end Athermal AWGs, announced the launching of new Ultra Low Loss Athermal AWG (ULL-AAWG) Multiplexer/Demultiplexer product which is shown in Figure 1.

Key Points: 
  • LOS ANGELES and SEOUL, South Korea, March 18, 2024 /PRNewswire/ -- POINTek, Inc., a global leader and provider of high performance high-end Athermal AWGs, announced the launching of new Ultra Low Loss Athermal AWG (ULL-AAWG) Multiplexer/Demultiplexer product which is shown in Figure 1.
  • "The Gaussian ULL-AAWG achieves ultra-low insertion loss of typically -1.5dB at the ±12.5GHz passband window.
  • The Flat-Top LL-AAWG achieves also low insertion loss of typically -3.5dB at the ±12.5GHz passband window, offering 2dB better than standard Flat-top AAWGs in the market," says Dr. T.H.
  • "Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.

ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses

Retrieved on: 
Wednesday, May 25, 2022

GENEVA, Switzerland May 25, 2022 ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for womens health, today announced the presentation of clinical data on linzagolix, an oral GnRH antagonist.

Key Points: 
  • GENEVA, Switzerland May 25, 2022 ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for womens health, today announced the presentation of clinical data on linzagolix, an oral GnRH antagonist.
  • The encouraging data presented at these important medical congresses highlight the differentiated therapeutic potential of linzagolix to better address the individual needs of women with uterine fibroids and endometriosis, said Dr. Brandi Howard, Chief Clinical Officer of ObsEva.
  • These data demonstrate that linzagolix with or without add-back therapy (ABT) significantly reduced heavy menstrual bleeding due to uterine fibroids.
  • Linzagolix is an investigational novel, once daily, oral GnRH receptor antagonist with a potentially best-in-class profile1,2,3.

Athermal AWG Multi/Demultiplexers in LGX Cassettes for 5G Wireless Fronthaul and High Density DWDM Channel Management

Retrieved on: 
Tuesday, August 31, 2021

LOS ANGELES and SEOUL, South Korea, Aug. 31, 2021 /PRNewswire/ --POINTek, Inc., a global leader and provider of high performance athermal AWGs, announced launching of newAthermal AWGMulti/Demultiplexer (MUX/DMX) products in various LGX cassettes for 5G wireless fronthaul application and high-density DWDM channel management .

Key Points: 
  • LOS ANGELES and SEOUL, South Korea, Aug. 31, 2021 /PRNewswire/ --POINTek, Inc., a global leader and provider of high performance athermal AWGs, announced launching of newAthermal AWGMulti/Demultiplexer (MUX/DMX) products in various LGX cassettes for 5G wireless fronthaul application and high-density DWDM channel management .
  • This 40-CH DWDM brick packaged in 2-slot LGX-short cassette supports solidly point-to-point 5G DWDM wireless fronthaul with bidirectional Blue/Red 20-CH DWDM Upstream and 20-CH DWDM Downstream ports.
  • This 40-CH DWDM brick is similar to that of the Metro Area 5G Wireless Fronthaulapplication, but is designed to support purely point-to-point 5G DWDM wireless fronthaulas well as FTTH.
  • "TheLGX cassettes with the low-loss Gaussian AWG bricks featured in these two 5G Wireless Fronthaul applications have been fully demonstrated and deployedin the field," says Dr. T.H.

CommScope Launches Coexistence Portfolio to Maximize GPON Fiber Networks

Retrieved on: 
Tuesday, August 31, 2021

CommScope today announced the launch of its Coexistence portfolio, designed for global service providers upgrading their existing PON networks to increase data speeds and deliver additional services without having to replace or add fiber to their existing PON infrastructure.

Key Points: 
  • CommScope today announced the launch of its Coexistence portfolio, designed for global service providers upgrading their existing PON networks to increase data speeds and deliver additional services without having to replace or add fiber to their existing PON infrastructure.
  • View the full release here: https://www.businesswire.com/news/home/20210831005297/en/
    CommScope Launches Coexistence Portfolio to Maximize GPON Fiber Networks (Photo: Business Wire)
    Our new CEx portfolio is a revolutionary solution for our GPON customers looking to achieve higher data rates and deliver new enterprise, mobile backhaul, and residential services without adding additional fiber, said James DeCoe, vice president, Network Connectivity, CommScope.
  • To find out more about the CEx portfolio, please visit the CommScope website or visit the CommScope booth #401 at ISE Expo, September 1st and 2nd.
  • CommScope (NASDAQ: COMM) is pushing the boundaries of technology to create the worlds most advanced wired and wireless networks.